New organoruthenium compounds with pyrido[2',3':5,6]pyrazino[2,3-f][1, 10]phenanthroline: synthesis, characterization, cytotoxicity, and investigation of mechanism of action.


Journal

Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry
ISSN: 1432-1327
Titre abrégé: J Biol Inorg Chem
Pays: Germany
ID NLM: 9616326

Informations de publication

Date de publication:
03 2019
Historique:
received: 06 12 2018
accepted: 28 01 2019
pubmed: 15 2 2019
medline: 29 2 2020
entrez: 15 2 2019
Statut: ppublish

Résumé

Three new ruthenium(II)-arene complexes with pyrido[2',3':5,6]pyrazino[2,3-f][1, 10]phenanthroline (ppf) of general formula: C1 ([(ƞ

Identifiants

pubmed: 30762123
doi: 10.1007/s00775-019-01647-4
pii: 10.1007/s00775-019-01647-4
doi:

Substances chimiques

Antineoplastic Agents 0
Coordination Complexes 0
Phenanthrolines 0
Ruthenium 7UI0TKC3U5

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

297-310

Références

Dalton Trans. 2014 Feb 14;43(6):2629-45
pubmed: 24327227
Angew Chem Int Ed Engl. 2016 Sep 19;55(39):11935-9
pubmed: 27571430
Proteomics Clin Appl. 2018 May;12(3):e1700124
pubmed: 29227035
Acc Chem Res. 2017 Nov 21;50(11):2727-2736
pubmed: 29058879
Dalton Trans. 2018 Oct 2;47(38):13696-13712
pubmed: 30209465
Clin Cancer Res. 2004 Jun 1;10(11):3717-27
pubmed: 15173078
J Inorg Biochem. 2016 Jul;160:250-5
pubmed: 26993078
Chem Commun (Camb). 2005 Oct 14;(38):4764-76
pubmed: 16193110
Cell Death Dis. 2018 Feb 15;9(3):260
pubmed: 29449532
Chem Soc Rev. 2017 Oct 2;46(19):5771-5804
pubmed: 28654103
Nat Chem. 2012 Jun 10;4(8):615-20
pubmed: 22824892
Methods Mol Biol. 1995;43:137-49
pubmed: 7550641
Chem Rev. 2019 Jan 23;119(2):797-828
pubmed: 30295467
Oncotarget. 2016 Jun 28;7(26):39473-39485
pubmed: 27250023
Chem Soc Rev. 2017 Nov 27;46(23):7317-7337
pubmed: 29027562
Dalton Trans. 2011 Sep 14;40(34):8611-21
pubmed: 21804968
Cell Death Differ. 2009 Jan;16(1):3-11
pubmed: 18846107
Pharmacol Ther. 2012 Oct;136(1):35-55
pubmed: 22796517
Dalton Trans. 2008 Jan 14;(2):183-94
pubmed: 18097483
Proc Natl Acad Sci U S A. 2010 Apr 20;107(16):7449-54
pubmed: 20368438
J Clin Oncol. 1988 Dec;6(12):1811-4
pubmed: 3199166
Chemistry. 2013 Oct 25;19(44):14768-72
pubmed: 24123460
Curr Protoc Immunol. 2001 May;Appendix 3:Appendix 3B
pubmed: 18432654
SLAS Discov. 2017 Jun;22(5):473-483
pubmed: 28288283
Dalton Trans. 2010 Feb 21;39(7):1673-88
pubmed: 20449402
Nature. 1952 Aug 2;170(4318):190-1
pubmed: 12982853
Cancer Biol Ther. 2017 Feb;18(2):106-114
pubmed: 27786591
J Inorg Biochem. 2006 May;100(5-6):891-904
pubmed: 16603249
J Med Chem. 2001 Oct 25;44(22):3616-21
pubmed: 11606126
Nat Rev Drug Discov. 2011 Mar;10(3):221-37
pubmed: 21358741
J Inorg Biochem. 2016 Oct;163:362-373
pubmed: 27118029
Nat Rev Drug Discov. 2005 Apr;4(4):307-20
pubmed: 15789122
J Inorg Biochem. 2016 Jul;160:156-65
pubmed: 26818702
Cancers (Basel). 2011 Mar 15;3(1):1351-71
pubmed: 24212665
Integr Biol (Camb). 2018 May 21;10(5):313-324
pubmed: 29721564
Cytometry. 1998 Jan 1;31(1):1-9
pubmed: 9450519
Arch Biochem Biophys. 1993 Jun;303(2):474-82
pubmed: 8390225
Chem Commun (Camb). 2018 Nov 20;54(93):13040-13059
pubmed: 30398487

Auteurs

Marijana Pavlović (M)

Institute for Oncology and Radiology of Serbia, Department of Experimental Oncology, Belgrade, Serbia.

Stefan Nikolić (S)

Innovation Center of the Faculty of Chemistry, University of Belgrade, Belgrade, Serbia.

Nevenka Gligorijević (N)

Institute for Oncology and Radiology of Serbia, Department of Experimental Oncology, Belgrade, Serbia.

Biljana Dojčinović (B)

Institute of Chemistry, Technology and Metallurgy, Centre of Chemistry, University of Belgrade, Belgrade, Serbia.

Sandra Aranđelović (S)

Institute for Oncology and Radiology of Serbia, Department of Experimental Oncology, Belgrade, Serbia.

Sanja Grgurić-Šipka (S)

Faculty of Chemistry, University of Belgrade, Belgrade, Serbia. sanjag@chem.bg.ac.rs.

Siniša Radulović (S)

Institute for Oncology and Radiology of Serbia, Department of Experimental Oncology, Belgrade, Serbia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH